Methylprednisolone and Erbitux drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Erbitux (cetuximab). Common drug interactions include convulsion among females and malaise among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Erbitux. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.

On Jul, 23, 2026

69 people who take Methylprednisolone and Erbitux together, and have interactions are studied.

Methylprednisolone and Erbitux drug interactions.

What are the common drug interactions of Methylprednisolone and Erbitux, by gender? *:

female:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Abdominal distension
Abdominal hernia obstructive (abdominal hernia causing a blockage)
Abdominal pain upper
Asthenia (weakness)
Back disorder
Back pain
Bacteraemia (presence of bacteria in the blood)
Bilirubin conjugated increased
Blood potassium increased

male:

Malaise (a feeling of general discomfort or uneasiness)
Amaurosis (partial or total blindness without visible change in the eye)
Death
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Hyperthermia (body temperature greatly above normal)
Oesophageal pain
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Methylprednisolone and Erbitux, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

30-39:

n/a

40-49:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Grand mal convulsion (a type of generalized seizure that affects the entire brain)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Catheter site infection (infection at the site of insertion)
Chills (felling of cold)
Hyperthermia (body temperature greatly above normal)
Intravascular haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood)
Lymphadenopathy (disease or enlargement of lymph nodes)
Nausea (feeling of having an urge to vomit)

50-59:

Vulvovaginal mycotic infection (vulvovaginal fungal infection)
Weight decreased
Abasia (inability to walk)
Abdominal hernia obstructive (abdominal hernia causing a blockage)
Abdominal pain upper
Blood magnesium increased
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cellulitis (infection under the skin)
Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

Pyrexia (fever)
Skin reaction
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Erythema (redness of the skin)
Hypokalaemia (low potassium)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Malaise (a feeling of general discomfort or uneasiness)
Oesophageal pain

What are the existing conditions these people have? *

Tonsil Cancer: 19 people, 27.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 19 people, 27.54%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 8 people, 11.59%
Colon Cancer: 7 people, 10.14%
Rectal Cancer (cancer of rectum): 5 people, 7.25%
Depression: 5 people, 7.25%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Erbitux?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously